|
"hsu ta"的相关文件
显示项目 61-83 / 83 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2009-08-01 |
Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors
|
Kang, IJ;Wang, LW;Hsu, SJ;Lee, CC;Lee, YC;Wu, YS;Hsu, TA;Yueh, A;Chao, YS;Chern, JH |
| 國家衛生研究院 |
2009-06-09 |
Treatment of coronavirus infection
|
Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW |
| 國家衛生研究院 |
2009-04-01 |
Design, synthesis, and anti-HCV activity of thiourea compounds
|
Kang, IJ;Wang, LW;Lee, CC;Lee, YC;Chao, YS;Hsu, TA;Chern, JH |
| 國家衛生研究院 |
2009-03 |
Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors
|
Hsieh, HP;Coumar, MS;Lin, CW;Reddy, GR;Tsai, MT;Lin, WH;Hsu, TA;Wu, SY |
| 國家衛生研究院 |
2008-12-11 |
吲哚化合物
|
Hsieh, HP;Mahindroo, N;Hsu, TA;Huang, CF;Chen, X;Chao, YS |
| 國家衛生研究院 |
2008-11-11 |
Indole compounds
|
Hsieh, HP;Mahindroo, NH;Hsu, TA;Huang, CF;Chen, X;Chao, YS |
| 國家衛生研究院 |
2008-02-11 |
一種抗病毒之醫藥組合物
|
Hsu, TA;Hsieh, HP;Juan, LJ;Chang, SY;Kuo, YH |
| 國家衛生研究院 |
2007-03-01 |
用於治療黃病毒科病毒感染之醫藥組合物、套組、及包裝產品
|
Hsu, TA;Tsai, YC;Hwang, DR |
| 國家衛生研究院 |
2006-08-01 |
抗腸病毒化合物
|
Chern, JH;Shia, KS;Shih, SR;Hsu, TA;Tai, CL |
| 國家衛生研究院 |
2006-04-19 |
用於治療黃病毒科病毒感染之醫藥組合物、套組、及包裝產品
|
Hsu, TA;Tsai, YC;Hwang, DR |
| 國家衛生研究院 |
2005-12-29 |
Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities
|
Mahindroo, N; Huang, CF; Peng, YH; Wang, CC; Liao, CC; Lien, TW; Chittimalla, SK; Huang, WJ; Chai, CH; Prakash, E; Chen, CP; Hsu, TA; Peng, CH; Lu, IL; Lee, LH; Chang, YW; Chen, WC; Chou, YC; Chen, CT; Goparaju, CMV; Chen, YS; Lan, SJ; Yu, MC; Chen, X; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2005-03 |
Promazine analogues as potential anti SARS-CoV drugs
|
Hsieh, HP;Wu, YS;Lu, PH;Chen, CM;Chao, YC;Jan, JT;Huei-Ru, L;Ma, SH;Chao, YS;Hsu, TA |
| 國家衛生研究院 |
2005-03 |
Design, synthesis and sar of indole-based PPAR agonists
|
Hsieh, HP;Mahindroo, N;Coumar, MS;Wang, CC;Huang, CF;Lien, TW;Tsai, CH;Lin, YT;Lee, LH;Prakash, E;Hsu, TA;Chen, X;Wu, SY;Chen, CT;Chao, YS |
| 國家衛生研究院 |
2005-03 |
Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents
|
Hsieh, HP;Mahindroo, N;Wang, CC;Huang, CF;Lien, TW;Tsai, CH;Peng, YH;Lee, LH;Prakash, E;Chen, WC;Chang, YW;Hsu, TA;Chen, X;Wu, SY;Chen, CT;Lan, SJ;Chao, YS |
| 國家衛生研究院 |
2004-11-09 |
Anti-enterovirus compounds
|
Chern, JH;Shia, KS;Shih, SR;Hsu, TA;Tai, CL |
| 國家衛生研究院 |
2004-05-17 |
Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidinies: a novel class of potent enterovirus inhibitors
|
Chern, JH; Shia, KS; Hsu, TA; Tai, CL; Lee, CC; Lee, YC; Chang, CS; Tseng, SN; Shih, SR |
| 國家衛生研究院 |
2003-12-10 |
Treatment of flaviviridae infection
|
Hsu, TA;Tsai, YC;Hwang, DR |
| 國家衛生研究院 |
2003-10 |
Sequential expression of recombinant proteins and their separate recovery from a Pichia pastoris cultivation
|
Wu, JM; Chieng, LL; Hsu, TA; Lee, CK |
| 國家衛生研究院 |
2003-09-10 |
Combined use of GAP and AOX1 promoter to enhance the expression of human granulocyte-macrophage colony-stimulating factor in Pichia pastoris
|
Wu, JM; Lin, JC; Chieng, LL; Lee, CK; Hsu, TA |
| 國家衛生研究院 |
2003-09 |
Expression of the gene coding for bacterial hemoglobin improves beta-galactosidase production in a recombinant Pichia pastoris
|
Wu, JM; Hsu, TA; Lee, CK |
| 國家衛生研究院 |
2002-02-15 |
The 3C protease activity of enterovirus 71 induces human neural cell apoptosis
|
Li, ML; Hsu, TA; Chen, TC; Chang, SC; Lee, JC; Chen, CC; Stollar, V; Shih, SR |
| 國家衛生研究院 |
2000-12 |
A baculovirus superinfection system: Efficient vehicle for gene transfer into Drosophila S2 cells
|
Lee, DF; Chen, CC; Hsu, TA; Juang, JL |
| 國家衛生研究院 |
1999 |
Formulation, stability, and delivery of live attenuated vaccines for human use
|
Burke, CJ; Hsu, TA; Volkin, DB |
显示项目 61-83 / 83 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目
|
